Population
Aspirin-treated platelets and saponin-permeabilized platelets
Comparison
Prostaglandin I2 and sodium nitroprusside vs Control conditions (absence of PGI2/SNP)
Design
Preclinical
Authors
Loading...
May advance preclinical platelet research; leaves open human translation or clinical relevance.
PGI2 and SNP inhibit platelet activation by promoting the phosphorylation and inhibition of the InsP3 receptor, thereby enhancing intracellular calcium reuptake.
Cavallini et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: